SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK Inhibitors.

MLA

Nayak, Rahul K., et al. “SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK Inhibitors.” Clinical Lymphoma, Myeloma & Leukemia, vol. 23, no. 12, Dec. 2023, pp. 861–65. EBSCOhost, https://doi.org/10.1016/j.clml.2023.08.011.

APA

Nayak, R. K., Gerber, D., Zhang, C., & Cohen, J. B. (2023). SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK Inhibitors. Clinical Lymphoma, Myeloma & Leukemia, 23(12), 861–865. https://doi.org/10.1016/j.clml.2023.08.011

Chicago

Nayak, Rahul K, Drew Gerber, Chen Zhang, and Jonathon B Cohen. 2023. “SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK Inhibitors.” Clinical Lymphoma, Myeloma & Leukemia 23 (12): 861–65. doi:10.1016/j.clml.2023.08.011.